Bioavailability Study of 2 Oral Formulations of ALXN1840
Clinical trial NCT04610580 · COMPLETED
Trial details
- NCT number
- NCT04610580
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-31
- Primary completion
- 2021-03-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.